By Professor Glenda Halliday

Journal articles

Prusiner SB; Woerman AL; Mordes DA; Watts JC; Rampersaud R; Berry DB; Patel S; Oehler A; Lowe JK; Kravitz SN; Geschwind DH; Glidden DV; Halliday GM; Middleton LT; Gentleman SM; Grinberg LT; Giles K, 2015, 'Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism', Proceedings of the National Academy of Sciences of the United States of America, 112, pp. E5308 - E5317, http://dx.doi.org/10.1073/pnas.1514475112

Coupland KG; Kim WS; Halliday GM; Hallupp M; Dobson-Stone C; Kwok JBJ, 2015, 'Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer’s disease', Current Alzheimer Research, 12, pp. 745 - 751, http://dx.doi.org/10.2174/1567205012666150710110756

Dzamko N; Geczy CL; Halliday GM, 2015, 'Inflammation is genetically implicated in Parkinson's disease', Neuroscience, 302, pp. 89 - 102, http://dx.doi.org/10.1016/j.neuroscience.2014.10.028

Cairns NJ; Perrin RJ; Franklin EE; Carter D; Vincent B; Xie M; Bateman RJ; Benzinger T; Friedrichsen K; Brooks WS; Halliday GM; Mclean C; Ghetti B; Morris JC, 2015, 'Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)', Neuropathology, 35, pp. 390 - 400, http://dx.doi.org/10.1111/neup.12205

Halliday GM, 2015, 'Re-evaluating the glio-centric view of multiple system atrophy by highlighting the neuronal involvement', Brain, 138, pp. 2116 - 2119, http://dx.doi.org/10.1093/brain/awv151

Fatima M; Tan R; Halliday GM; Kril JJ, 2015, 'Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways', Acta neuropathologica communications, 3, pp. 47, http://dx.doi.org/10.1186/s40478-015-0226-y

Mills JD; Chen J; Kim WS; Waters PD; Prabowo AS; Aronica E; Halliday GM; Janitz M, 2015, 'Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter', Neurogenetics, 16, pp. 201 - 213, http://dx.doi.org/10.1007/s10048-015-0445-1

Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WDJ; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DMA; Imai Y; Halliday GM; Li JY; El-Agnaf OMA, 2015, 'Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology', Neurobiology of Disease, 79, pp. 81 - 99, http://dx.doi.org/10.1016/j.nbd.2015.04.009

Ittner LM; Halliday GM; Kril JJ; Götz J; Hodges JR; Kiernan MC, 2015, 'FTD and ALS-translating mouse studies into clinical trials', Nature Reviews Neurology, 11, pp. 360 - 366, http://dx.doi.org/10.1038/nrneurol.2015.65

Shine JM; Mills JMZ; Qiu J; O'Callaghan C; Terpening Z; Halliday GM; Naismith SL; Lewis SJG, 2015, 'Validation of the Psychosis and Hallucinations Questionnaire in Non-demented Patients with Parkinson's Disease', Movement Disorders Clinical Practice, 2, pp. 175 - 181, http://dx.doi.org/10.1002/mdc3.12139

Duyckaerts C; Braak H; Brion JP; Buée L; Del Tredici K; Goedert M; Halliday G; Neumann M; Spillantini MG; Tolnay M; Uchihara T, 2015, 'PART is part of Alzheimer disease', Acta Neuropathologica, 129, pp. 749 - 756, http://dx.doi.org/10.1007/s00401-015-1390-7

Cheshire P; Ayton S; Bertram KL; Ling H; Li A; Mclean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR, 2015, 'Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias', Movement Disorders, 30, pp. 796 - 804, http://dx.doi.org/10.1002/mds.26144

Shine JM; Muller AJ; O'Callaghan C; Hornberger M; Halliday GM; Lewis SJG, 2015, 'Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson's disease: A task-based fMRI study', Parkinson's Disease, 1, http://dx.doi.org/10.1038/npjparkd.2015.3

Ahmed R; Henning E; Bartley L; Halliday G; Piguet O; Farooqi S; Hodges J; Kiernan M, 2015, 'Eating Behaviour and Metabolic Changes across the Spectrum of Motor Neuron Disease and Frontotemporal Dementia. (I12-5E)', Neurology, 84, http://dx.doi.org/10.1212/wnl.84.14_supplement.i12-5e

Ahmed R; Henning E; Bartley L; Halliday G; Piguet O; Farooqi S; Hodges J; Kiernan M, 2015, 'Eating Behaviour and Metabolic Changes across the Spectrum of Motor Neuron Disease and Frontotemporal Dementia. (P1.225)', Neurology, 84, http://dx.doi.org/10.1212/wnl.84.14_supplement.p1.225

Halliday GM; Murphy KE, 2015, 'Reply: Lysosomal dysfunction in Parkinson's disease', Brain, 138, pp. e340, http://dx.doi.org/10.1093/brain/awu268

Mills JD; Kim WS; Halliday GM; Janitz M, 2015, 'Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy', Neurogenetics, 16, pp. 107 - 122, http://dx.doi.org/10.1007/s10048-014-0430-0

Yang Y; Shepherd C; Halliday G, 2015, 'Aneuploidy in Lewy body diseases', Neurobiology of Aging, 36, pp. 1253 - 1260, http://dx.doi.org/10.1016/j.neurobiolaging.2014.12.016

Halliday G, 2015, 'Progressive supranuclear palsy finally has a clinically measureable τ abnormality', Journal of Neurology, Neurosurgery and Psychiatry, 86, pp. 241, http://dx.doi.org/10.1136/jnnp-2014-308567

Mills JD; Kavanagh T; Kim WS; Chen BJ; Waters PD; Halliday GM; Janitz M, 2015, 'High expression of long intervening non-coding RNA OLMALINC in the human cortical white matter is associated with regulation of oligodendrocyte maturation', Molecular brain, 8, pp. 2, http://dx.doi.org/10.1186/s13041-014-0091-9

Fu Y; Hsiao JHT; Paxinos G; Halliday GM; Kim WS, 2015, 'ABCA5 Regulates amyloid-β peptide production and is associated with Alzheimer's disease neuropathology', Journal of Alzheimer's Disease, 43, pp. 857 - 869, http://dx.doi.org/10.3233/JAD-141320

Abbott SK; Jenner AM; Spiro AS; Batterham M; Halliday GM; Garner B, 2015, 'Fatty acid composition of the anterior cingulate cortex indicates a high susceptibility to lipid peroxidation in Parkinson's disease', Journal of Parkinson's Disease, 5, pp. 175 - 185, http://dx.doi.org/10.3233/JPD-140479

Halliday GM; Forrest SL; Kril J, 2015, 'Frontotemporal lobar degeneration with tau inclusions (FTLD-tau): Recent developments in pathology and pathogenesis', Australian Biochemist, 46, pp. 8 - 11

McCann H; McGeachie AB; Silberstein P; Lewis SJG; Halliday GM, 2015, 'Restricted disease propagation in multiple system atrophy with prolonged survival', Neuropathology and Applied Neurobiology, 41, pp. 681 - 685, http://dx.doi.org/10.1111/nan.12195

Huang Y; Wang G; Rowe D; Wang Y; Kwok JBJ; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G, 2015, 'SNCA gene, but not MAPT, influences onset age of Parkinson's disease in Chinese and Australians', BioMed Research International, 2015, pp. 135674, http://dx.doi.org/10.1155/2015/135674

Tan RH; Devenney E; Kiernan MC; Halliday GM; Hodges JR; Hornberger M, 2015, 'Terra incognita-cerebellar contributions to neuropsychiatric and cognitive dysfunction in behavioral variant frontotemporal dementia', Frontiers in Aging Neuroscience, 7, http://dx.doi.org/10.3389/fnagi.2015.00121

Szeto JYY; O'Callaghan C; Shine JM; Walton CC; Mowszowski L; Naismith SL; Halliday GM; Lewis SJG, 2015, 'The relationships between mild cognitive impairment and phenotype in Parkinson's disease', Parkinson's Disease, 1, http://dx.doi.org/10.1038/npjparkd.2015.15

Chen J; Mills JD; Halliday GM; Janitz M, 2015, 'The role of transcriptional control in multiple system atrophy', Neurobiology of Aging, 36, pp. 394 - 400, http://dx.doi.org/10.1016/j.neurobiolaging.2014.08.015

Sandin L; Nath S; Armstrong A; Janefjord C; McCann H; Halliday GM; Blennow K; Zetterberg H; Brorsson A-C; Kagedal K, 2015, 'P1‐316: The role of lysozyme in Alzheimer's disease', Alzheimer's & Dementia, 11, http://dx.doi.org/10.1016/j.jalz.2015.06.531

Ahmed RM; Paterson RW; Warren JD; Zetterberg H; O'Brien JT; Fox NC; Halliday GM; Schott JM, 2014, 'Biomarkers in dementia: Clinical utility and new directions', Journal of Neurology, Neurosurgery and Psychiatry, 85, pp. 1426 - 1434, http://dx.doi.org/10.1136/jnnp-2014-307662

Stoessl AJ; Halliday GM, 2014, 'DAT-SPECT diagnoses dopamine depletion, but not PD', Movement Disorders, 29, pp. 1705 - 1706, http://dx.doi.org/10.1002/mds.26000

Bras J; Guerreiro R; Darwent L; Parkkinen L; Ansorge O; Escott-Price V; Hernandez DG; Nalls MA; Clark LN; Honig LS; Marder K; Van Der Flier WM; Lemstra A; Scheltens P; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Ortega-Cubero S; Pastor P; Ferman TJ; Graff-Radford NR; Ross OA; Barber I; Braae A; Brown K; Morgan K; Maetzler W; Berg D; Troakes C; Al-Sarraj S; Lashley T; Compta Y; Revesz T; Lees A; Cairns N; Halliday GM; Mann D; Pickering-Brown S; Dickson DW; Singleton A; Hardy J, 2014, 'Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies', Human molecular genetics, 23, pp. 6139 - 6146, http://dx.doi.org/10.1093/hmg/ddu334

Ahmed RM; MacMillan M; Bartley L; Halliday GM; Kiernan MC; Hodges JR; Piguet O, 2014, 'Systemic metabolism in frontotemporal dementia', Neurology, 83, pp. 1812 - 1818, http://dx.doi.org/10.1212/WNL.0000000000000993

Muller AJ; Shine JM; Halliday GM; Lewis SJG, 2014, 'Visual hallucinations in Parkinson's disease: Theoretical models', Movement Disorders, 29, pp. 1591 - 1598, http://dx.doi.org/10.1002/mds.26004

Riley BE; Gardai SJ; Emig-Agius D; Bessarabova M; Ivliev AE; Schüle B; Alexander J; Wallace W; Halliday GM; Langston JW; Braxton S; Yednock T; Shaler T; Johnston JA, 2014, 'Systems-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanisms', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0102909

Tan RH; Devenney E; Dobson-Stone C; Kwok JB; Hodges JR; Kiernan MC; Halliday GM; Hornberger M, 2014, 'Cerebellar integrity in the amyotrophic lateral sclerosis - Frontotemporal dementia continuum', PLoS ONE, 9, pp. e105632, http://dx.doi.org/10.1371/journal.pone.0105632

Halliday G, 2014, 'Progressive supranuclear palsy finally has a clinically measureable τ abnormality', Journal of Neurology, Neurosurgery and Psychiatry, http://dx.doi.org/10.1136/jnnp-2014-308567

Dzamko N; Zhou J; Huang Y; Halliday GM, 2014, 'Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis', Frontiers in Molecular Neuroscience, 7, http://dx.doi.org/10.3389/fnmol.2014.00057

Halliday GM; Leverenz JB; Schneider JS; Adler CH, 2014, 'The neurobiological basis of cognitive impairment in Parkinson's disease', Movement Disorders, 29, pp. 634 - 650, http://dx.doi.org/10.1002/mds.25857

Davies KM; Bohic S; Carmona A; Ortega R; Cottam V; Hare DJ; Finberg JPM; Reyes S; Halliday GM; Mercer JFB; Double KL, 2014, 'Copper pathology in vulnerable brain regions in Parkinson's disease', Neurobiology of Aging, 35, pp. 858 - 866, http://dx.doi.org/10.1016/j.neurobiolaging.2013.09.034

Don AS; Hsiao JHT; Bleasel JM; Couttas TA; Halliday GM; Kim WS, 2014, 'Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy', Acta Neuropathologica Communications, 2, http://dx.doi.org/10.1186/s40478-014-0150-6

Murphy KE; Cottle L; Gysbers AM; Cooper AA; Halliday GM, 2014, 'ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies', Acta Neuropathologica Communications, 2, http://dx.doi.org/10.1186/2051-5960-1-11

Tan RH; Shepherd CE; Kril JJ; McCann H; McGeachie A; McGinley C; Affleck A; Halliday GM, 2014, 'Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43', Acta Neuropathologica Communications, 2, http://dx.doi.org/10.1186/2051-5960-1-33

Bleasel JM; Wong JH; Halliday GM; Kim WS, 2014, 'Lipid dysfunction and pathogenesis of multiple system atrophy', Acta Neuropathologica Communications, 2, http://dx.doi.org/10.1186/2051-5960-2-15

Howitt J; Gysbers AM; Ayton S; Carew-Jones F; Putz U; Finkelstein DI; Halliday GM; Tan SS, 2014, 'Increased Ndfip1 in the substantia nigra of parkinsonian brains is associated with elevated iron levels', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0087119

Kim WS; Kagedal K; Halliday GM, 2014, 'Alpha-synuclein biology in Lewy body diseases', Alzheimer's Research and Therapy, 6, http://dx.doi.org/10.1186/s13195-014-0073-2

Abbott SK; Li H; Muñoz SS; Knoch B; Batterham M; Murphy KE; Halliday GM; Garner B, 2014, 'Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease', Movement Disorders, 29, pp. 518 - 526, http://dx.doi.org/10.1002/mds.25729

Tan RH; Wong S; Kril JJ; Piguet O; Hornberger M; Hodges JR; Halliday GM, 2014, 'Beyond the temporal pole: Limbic memory circuit in the semantic variant of primary progressive aphasia', Brain, 137, pp. 2065 - 2076, http://dx.doi.org/10.1093/brain/awu118

Mahul-Mellier AL; Fauvet B; Gysbers A; Dikiy I; Oueslati A; Georgeon S; Lamontanara AJ; Bisquertt A; Eliezer D; Masliah E; Halliday G; Hantschel O; Lashuel HA, 2014, 'C-Abl phosphorylates α-synuclein and regulates its degradation: Implication for α-synuclein clearance and contribution to the pathogenesis of parkinson's disease', Human Molecular Genetics, 23, pp. 2858 - 2879, http://dx.doi.org/10.1093/hmg/ddt674

Blennerhassett R; Lillo P; Halliday GM; Hodges JR; Kril JJ, 2014, 'Distribution of pathology in frontal variant Alzheimer's disease', Journal of Alzheimer's Disease, 39, pp. 63 - 70, http://dx.doi.org/10.3233/JAD-131241

Back to profile page